| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Fink Jeffrey Arvin is a Director at Lipocine Inc.. Recent SEC Form 4 filings include 0 buys and 1 sell.
Estimated insider holdings value: $15K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 29, 2017 | LPCN Lipocine Inc. | Director | Sale+OE | 938 | $3.47 | $3,258.33 | -50.0% |